loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Oxalic Acid

    Client Email Product
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    Oxalic Acid

    ACTIVE PHARMA INGREDIENTS

    PRICE INFORMATION

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    $ API Ref.Price (USD/KG) : 565Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Tonix Announces Issuance of U.S. Patent for and Uses of Tianeptine Oxalate
    Tonix Announces Issuance of U.S. Patent for and Uses of Tianeptine Oxalate

    19 Mar 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2021/03/19/2196082/0/en/Tonix-Pharmaceuticals-Announces-Issuance-of-U-S-Patent-for-Compositions-and-Uses-of-Tianeptine-Oxalate-Salt-the-Active-Ingredient-of-TNX-601-CR.html

    GLOBENEWSWIRE
    19 Mar 2021
    Share Share
    Dicerna’s nedosiran achieves urinary oxalate normalisation in PH trial
    Dicerna’s nedosiran achieves urinary oxalate normalisation in PH trial

    23 Oct 2020

    // CLINICALTRAILSARENA

    https://www.clinicaltrialsarena.com/news/dicerna-nedosiran-urinary-oxalate/

    CLINICALTRAILSARENA
    23 Oct 2020
    Share Share
    Alnylam preps next filing as rare kidney disease med aces phase 3
    Alnylam preps next filing as rare kidney disease med aces phase 3

    18 Dec 2019

    // A. Al Idrus FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/alnylam-preps-next-filing-as-rare-kidney-disease-med-aces-phase-3

    A. Al Idrus FIERCE BIOTECH
    18 Dec 2019
    Share Share
    BeeVital GmbH VarroMed Receives Approval In Europe
    BeeVital GmbH VarroMed Receives Approval In Europe

    10 Apr 2017

    // EMA

    http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004016/human_med_002088.jsp&mid=WC0b01ac058001d124

    EMA
    10 Apr 2017
    Share Share